Filing Details
Organon & Co. (NYSE:OGN) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on July 31, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNYSE:OGN
Organon & Co. (OGN) Files Quarterly Report for Q0
Filing Details Organon & Co. (NYSE:OGN) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on July 31, 2026. The Healthcare company reported Q0…
Market Context
Organon & Co.'s stock currently trades at $13.55 with a market capitalization of $1.9B.
The 10-Q provides Organon & Co.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Organon & Co. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View OGN Stock Page
Frequently Asked Questions
Where can I read OGN's SEC filings?
Browse all filings on our OGN SEC filings page.
What types of SEC filings does Organon & Co. file?
Public companies like Organon & Co. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.